Muheim, Jane
Hotz, Isabella
Kübler, Franziska
Herren, Silvia
Sollereder, Simon
Kruszewski, Katharina
Martin‑Niedecken, Anna Lisa
Schättin, Alexandra
Behrendt, Frank
Böckler, Sonja
Schmidlin, Stefan
Jurt, Roman
Niedecken, Stephan
Riederer, Yanick
Brenneis, Christian
Bonati, Leo H.
Seebacher, Barbara
Schuster‑Amft, Corina
Funding for this research was provided by:
Active and Assisted Living programme (AAL-2020-7-48-CP, AAL-2020-7-48-CP, AAL-2020-7-48-CP, AAL-2020-7-48-CP, AAL-2020-7-48-CP, AAL-2020-7-48-CP, AAL-2020-7-48-CP, AAL-2020-7-48-CP, AAL-2020-7-48-CP, AAL-2020-7-48-CP, AAL-2020-7-48-CP, AAL-2020-7-48-CP)
University of Basel
Article History
Received: 21 September 2023
Accepted: 9 December 2024
First Online: 21 December 2024
Declarations
:
: In Switzerland, ethics approval was obtained from the ethics committee of Northwest- and Central Switzerland (EKNZ) under reference number 2022-00559. In Austria, ethics approval was obtained from the ethics committee of the Medical University of Innsbruck under reference number 1004/2022. This study was prospectively registered on 09.06.2022 with the German Clinical Trials Register (DRKS00029211). Written informed consent to participate was obtained from all participants prior to data collection. In addition, the study team member gave informed consent for the publication of Figure .
: Consent for publication obtained. In addition, the study team member depicted in Figure gave informed consent for its publication.
: In addition to their research career, AM-N, AS and SN also work for Sphery Ltd. AM-N and SN are co-founders of the start-up company Sphery Ltd, which developed the ExerCube based on the results of previous research projects. AS was employed by Sphery as Senior Research and Development Manager from November 2019 to February 2023. The remaining authors have no conflicts of interest to declare. No revenue was paid or promised to be paid directly to AM-N, AS, SN, Sphery Ltd or any of the authors and research institutions.